Catalyst Pharmaceuticals
Presence
Catalyst Pharmaceuticals is one of the...
Catalyst Pharmaceuticals is a company listed under the stock ticker CPRX (US).
Executives
View the org chart displaying its 17 main executives
Most searched biographies at Catalyst Pharmaceuticals
- Patrick McEnany, Non-Executive Chairman of the Board
- Richard Daly, Director and Chief Executive Officer
- David Tierney, Director
Popular executive movements at Catalyst Pharmaceuticals
- Michael Kalb will join the company as Executive Vice President and Chief Financial Officer on Jan. 1, 2024 (posted on December 5 2023).
- Alicia Grande, Vice President, Chief Financial Officer and Treasurer, will retire on Dec. 31, 2023 (posted on December 5 2023).
- Richard Daly who is Member of the Board, will be promoted to Director and Chief Executive Officer on Jan. 1, 2024 (posted on October 19 2023).
Click here to view some more movements at Catalyst Pharmaceuticals
Create your alert
to follow the executive moves at Catalyst Pharmaceuticals.
Pharmaceuticals
Catalyst Pharmaceuticals has 1,865 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
- Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Catalyst Pharmaceuticals
- Catalyst Pharmaceuticals To Participate in Piper Sandler 35th Annual Healthcare Conference : Catalyst Pharmaceutical
- Catalyst Pharmaceuticals Reports Strong Third Quarter 2023 Financial Results and Corporate Update : Catalyst Pharmaceutical
- Press Releases : Catalyst Pharmaceutical
- Catalyst Pharmaceuticals Reports FDA Approval of AGAMREE® (vamorolone) for Duchenne Muscular Dystrophy Granted to Santhera Pharmaceuticals : Catalyst Pharmaceutical
- Catalyst Pharmaceuticals Receives Two New U.S. Patent Allowances For FIRDAPSE® : Catalyst Pharmaceutical
- Catalyst Pharmaceuticals Partners with Sofie's Journey to Bring Focus on Epilepsy at the 11th Annual Epilepsy Awareness and Education Expo : Catalyst Pharmaceutical
- Catalyst Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 8, 2023 : Catalyst Pharmaceutical
- Catalyst Pharmaceuticals to Participate at the 2023 Cantor Global Healthcare Conference : Catalyst Pharmaceutical
- Catalyst Pharmaceuticals Announces FDA Acceptance of the Supplemental New Drug Application for FIRDAPSE® : Catalyst Pharmaceutical
- Catalyst Pharmaceuticals Appoints Richard J. Daly as Chief Executive Officer : Catalyst Pharmaceutical
- View more press releases Close
Social media about Catalyst Pharmaceuticals
- Catalyst Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
- Catalyst Pharmaceuticals on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Patrick McEnany 
Call Catalyst Pharmaceuticals at +1 305...
